EPISODE · May 4, 2021 · 18 MIN
What’s Material in ESG for Biopharma Firms?
For biopharma companies, ESG commitments can look considerably different from other sectors. We spoke with the team of ESG leads at Gilead Sciences to understand the five key components driving its ESG strategy, how it’s evolved and how it impacts their business.
Embed this episode
NOW PLAYING
What’s Material in ESG for Biopharma Firms?
0:00
18:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 18 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on May 4, 2021.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!